Skip to content
healthcare.dev

BEYFORTUS

NDC 49281-575, nirsevimab, injection, from Sanofi Vaccines US Inc..

Product NDC
49281-575
Status
Listed
Labeler
Sanofi Vaccines US Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761328
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49281-575 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NIRSEVIMAB100 mg/mL

Pharmacologic classes

Fusion Protein Inhibitors [MoA]; Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]

Package NDCNDC-11Package
49281-575-00492810575001 SYRINGE in 1 CARTON (49281-575-00) / .5 mL in 1 SYRINGE
49281-575-15492810575155 SYRINGE in 1 CARTON (49281-575-15) / .5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2f08fa60-f674-432d-801b-1f9514bd9b39

Use it

Look up 49281-575 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49281-575 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49281-575. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.